A decade ago, chimeric antigen receptor T-cell (CAR-T) therapy was still an experimental treatment, available only through clinical trials. Today, Mayo Clinic offers this life-changing therapy at all three of its major campuses — in Arizona, Florida, and Minnesota — and continues to push its boundaries. Even more recently, personalized mRNA cancer vaccines and focused ultrasound ablation have emerged as promising new tools against tumors. Looking ahead, what additional breakthroughs are we likely to see in the next few years that could deliver truly effective, durable treatments for a wider range of cancers? *In the next 3–7 years, cancer treatment is expected to shift from “one-size-fits-most” approaches toward highly personalized, multi-modal strategies that combine immune engineering, physical disruption of tumors, and rapid molecular design.* Here’s a realistic view of developments already advancing and likely to prove clinically meaningful: 1. Next-generati...
Dr.Srinivasa Raju
Its a web blog of Dr.Srinivasa Raju,ENT Surgeon from ELURU of A.P. Dr. C S Raju is a Member of IMA& A.P.Medical council& Association of otorhinolaryngology &Member of the Red cross society. DrCSRaju is CWC Member of IMA HQ &Past state president of IMA AP. This blog is for up dates on-" current affairs, Medical fraternity, Medico-legal information, Health care acts. The content can not be copied. please mail csrajuent10@gmail.com for all queries and suggestions.